Home › Funds › Front Street Capital Management, Inc. › ENOV

Front Street Capital Management, Inc. position in ENOV

ENOVIS CORPORATION · Health Care

Front Street Capital Management, Inc. reported holding 1,449,586 shares of ENOV (ENOVIS CORPORATION) in its Q3 2026 13F filing — a position valued at US$26.5M, representing 3.30% of its reported portfolio and ranking #11 among its reported holdings. Front Street Capital Management, Inc. has disclosed ENOV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.45M sh
Reported value held$26.48M
Portfolio Weight3.30%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Front Street Capital Management, Inc.'s ENOV position evolved

Front Street Capital Management, Inc. first disclosed a stake in ENOV in Q3 2023 at 198,884 shares (US$10.3M). The position peaked in Q3 2026 at 1,449,586 shares, worth US$26.5M. Across 13 filings, Front Street Capital Management, Inc. increased the stake 9 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,449,586 shares valued at US$26.5M — an increase of 661,686 shares quarter over quarter.. Notable position changes include a 76% increase in Q4 2025 (shares fell 15% over the following quarter), a 106% increase in Q1 2026 (shares fell 9% over the following quarter), a 84% increase in Q3 2026 (shares rose 52% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 198.88K $10.27M New
Q4 2023 207.57K $11.63M Add
Q1 2024 207.25K $12.94M Hold
Q2 2024 210.54K $9.52M Add
Q3 2024 228.89K $9.85M Add
Q4 2024 257.51K $11.30M Add
Q1 2025 259.78K $9.93M Add
Q2 2025 207.72K $6.51M Reduce
Q3 2025 205.86K $6.25M Reduce
Q4 2025 361.93K $9.64M Add
Q1 2026 746.06K $16.97M Add
Q2 2026 787.90K $16.31M Add
Q3 2026 1.45M $26.48M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ENOV and 13F data

ENOV (ENOVIS CORPORATION) is a Health Care company. 16 other funds we track also report a position in ENOV — the largest reported positions include Rubric Capital Management LP (US$80.7M), OAKTREE CAPITAL MANAGEMENT LP (US$37.8M), PRIVATE MANAGEMENT GROUP INC (US$32.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ENOV

All ENOV fund holders →

FAQ

How long has Front Street Capital Management, Inc. held ENOV?

Front Street Capital Management, Inc. has disclosed ENOV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Front Street Capital Management, Inc.'s current position in ENOV?

As of Q3 2026, Front Street Capital Management, Inc. holds 1.45M shares of ENOV (ENOVIS CORPORATION), valued at $26.48M, representing 3.30% of its reported portfolio and ranking #11.

Has Front Street Capital Management, Inc. been buying or selling ENOV?

In the latest 13F filing (Q3 2026), Front Street Capital Management, Inc. increased its position in ENOV. The position peaked in Q3 2026 at 1.45M shares.

Which other funds hold ENOV?

Other major institutional holders of ENOV include Rubric Capital Management LP, OAKTREE CAPITAL MANAGEMENT LP, PRIVATE MANAGEMENT GROUP INC, among 16 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.